TTM
$2.85B
YoY change
-10.7%
5Y CAGR
-12.2%
Peak year (2020)
$5.57B
Cumulative EBITDA
$38.27B
EBITDA history chart for Humana (HUM) from 1990 to 2025
Latest: $2.91B
EBITDA growth chart for Humana (HUM) from 1990 to 2025
Latest: -10.7%
EBITDA history table for Humana (HUM) from 1990 to 2025
| 2025 | $2.91B | -10.7% | −$347.00M | ||
| 2024 | $3.25B | -31.2% | −$1.48B | ||
| 2023 | $4.73B | -1.7% | −$80.00M | ||
| 2022 | $4.81B | +7.9% | +$352.00M | ||
| 2021 | $4.46B | -20.0% | −$1.11B | ||
| 2020 | $5.57B | +30.0% | +$1.29B | ||
| 2019 | $4.29B | +51.7% | +$1.46B | ||
| 2018 | $2.83B | -401.9% | +$3.76B | ||
| 2017 | −$936.00M | — | −$936.00M | ||
| 2016 | $0.00 | -100.0% | +$270.00M | ||
| 2015 | −$270.00M | — | −$270.00M | ||
| 2014 | $0.00 | — | $0.00 | ||
| 2013 | $0.00 | -100.0% | −$46.00M | ||
| 2012 | $46.00M | — | +$46.00M | ||
| 2011 | $0.00 | -100.0% | −$162.40M | ||
| 2010 | $162.40M | — | +$162.40M | ||
| 2009 | $0.00 | -100.0% | −$103.10M | ||
| 2008 | $103.10M | — | +$103.10M | ||
| 2007 | $0.00 | — | $0.00 | ||
| 2006 | $0.00 | -100.0% | −$461.03M | ||
| 2005 | $461.03M | -15.6% | −$85.28M | ||
| 2004 | $546.31M | +13.7% | +$65.95M | ||
| 2003 | $480.36M | +40.6% | +$138.83M | ||
| 2002 | $341.53M | -10.0% | −$37.88M | ||
| 2001 | $379.40M | +28.1% | +$83.18M | ||
| 2000 | $296.22M | -221.2% | +$540.71M | ||
| 1999 | −$244.48M | -164.7% | −$622.54M | ||
| 1998 | $378.06M | +195.4% | +$250.06M | ||
| 1997 | $128.00M | +17.4% | +$19.00M | ||
| 1996 | $109.00M | +34.6% | +$28.00M | ||
| 1995 | $81.00M | -75.6% | −$251.00M | ||
| 1994 | $332.00M | +514.8% | +$278.00M | ||
| 1993 | $54.00M | -82.5% | −$255.00M | ||
| 1992 | $309.00M | -12.5% | −$44.00M | ||
| 1991 | $353.00M | +3.2% | +$10.80M | ||
| 1990 | $342.20M | — | — |
- 2025$2.91B-10.7%
- 2024$3.25B-31.2%
- 2023$4.73B-1.7%
- 2022$4.81B+7.9%
- 2021$4.46B-20.0%
- 2020$5.57B+30.0%
- 2019$4.29B+51.7%
- 2018$2.83B-401.9%
- 2017−$936.00M—
- 2016$0.00-100.0%
- 2015−$270.00M—
- 2014$0.00—
- 2013$0.00-100.0%
- 2012$46.00M—
- 2011$0.00-100.0%
- 2010$162.40M—
- 2009$0.00-100.0%
- 2008$103.10M—
- 2007$0.00—
- 2006$0.00-100.0%
- 2005$461.03M-15.6%
- 2004$546.31M+13.7%
- 2003$480.36M+40.6%
- 2002$341.53M-10.0%
- 2001$379.40M+28.1%
- 2000$296.22M-221.2%
- 1999−$244.48M-164.7%
- 1998$378.06M+195.4%
- 1997$128.00M+17.4%
- 1996$109.00M+34.6%
- 1995$81.00M-75.6%
- 1994$332.00M+514.8%
- 1993$54.00M-82.5%
- 1992$309.00M-12.5%
- 1991$353.00M+3.2%
- 1990$342.20M—
EBITDA values are taken from Humana's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Humana (HUM)
According to Humana's latest reported financial statements, the company's current EBITDA (TTM) is $2.85B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Humana (HUM) EBITDA totalled $2.91B – declined 10.7% year-over-year.
Humana EBITDA has contracted on net over the period, with a -12.2% compound annual growth rate over 2020–2025 (5 years).
Humana EBITDA peaked at $5.57B in 2020; the latest annual figure is $2.91B in 2025 (47.8% below peak).
The record annual EBITDA stands at $5.57B, reached in 2020; the historical low of −$936.00M was recorded in 2017.
Humana EBITDA by Year
Humana EBITDA 2025: $2.91B
Humana posted EBITDA of $2.91B in 2025, declined 10.7% below 2024.
Humana EBITDA 2024: $3.25B
In 2024, Humana reported EBITDA of $3.25B, plunged 31.2% below 2023.
Humana EBITDA 2023: $4.73B
Humana EBITDA in 2023 was $4.73B, edged down 1.7% below 2022.
Humana EBITDA 2022: $4.81B
2022's EBITDA for Humana came in at $4.81B, grew 7.9% from 2021.
Humana EBITDA 2021: $4.46B
Humana EBITDA in 2021 was $4.46B.
See more financial history for Humana (HUM).
Sector peers by EBITDA
Healthcare peers of Humana (HUM), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Humana (HUM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation